<DOC>
	<DOCNO>NCT01973205</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety acetaminophen aspirin versus placebo acute treatment migraine</brief_summary>
	<brief_title>Efficacy Safety Acetaminophen Aspirin Versus Placebo Acute Treatment Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Inclusion criterion : 1 . Male female age 18 year . 2. International Headache Society ( IHS ) diagnosis migraine without aura typical aura migraine headache . 3 . History experience least 1 , 8 , acute migraine attack monthly previous year . 4 . History least moderate migraine pain intensity , leave untreated . 5 . History frequently always experience nausea migraine attack . Exclusion criterion : Subjects eligible inclusion study must fulfill follow criterion : 1 . Headache symptom may due aggravate : Recent ( within 6 month ) head neck trauma ( e.g. , whiplash ) Head neck pain secondary orthopedic abnormality Cluster headache Specific migraine variant ( e.g. , basilartype artery migraine , opthalmoplegic migraine , hemiplegic migraine , migraine aura without headache ) Other serious , nonmigraine cause headache ( e.g. , increased intracranial pressure , intracranial bleeding , meningitis , malignancy ) Nonserious , nonmigraine cause headache ( e.g. , cold , flu , hangover ) 2 . History vomit 20 % migraine attack . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Migraine</keyword>
	<keyword>acetaminophen</keyword>
	<keyword>aspirin</keyword>
</DOC>